82 FR 12364 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 40 (March 2, 2017)

Page Range		12364-12364
FR Document		2017-04025

Federal Register, Volume 82 Issue 40 (Thursday, March 2, 2017)

[Federal Register Volume 82, Number 40 (Thursday, March 2, 2017)]
[Notices]
[Page 12364]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04025]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Technical Support for Constituency Outreach & 
Research Dissemination (1157).
    Date: April 4, 2017.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Purity Specifications, Storage & Distribution for 
Medications Development (8934).
    Date: April 20, 2017.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: February 24, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04025 Filed 3-1-17; 8:45 am]
BILLING CODE 4140-01-P

12364 Federal Register / Vol. 82, No. 40 / Thursday, March 2, 2017 / Notices

Contents Dated: February 28, 2017. Addiction Research Programs, National
William N. Parham, III, Institutes of Health, HHS)
This notice sets out a summary of the Director, Paperwork Reduction Staff, Office Dated: February 24, 2017.
use and burden associated with the of Strategic Operations and Regulatory Natasha M. Copeland,
following ICR. More detailed Affairs. Program Analyst, Office of Federal Advisory
information can be found in the [FR Doc. 2017–04160 Filed 3–1–17; 8:45 am] Committee Policy.
collection’s supporting statement and BILLING CODE 4120–01–P [FR Doc. 2017–04025 Filed 3–1–17; 8:45 am]
associated materials (see ADDRESSES).
BILLING CODE 4140–01–P
CMS–R–39 Home Health Conditions of
Participation (CoP) and Supporting DEPARTMENT OF HEALTH AND
Regulations HUMAN SERVICES DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Under the PRA (44 U.S.C. 3501– National Institutes of Health
3520), federal agencies must obtain National Institutes of Health
approval from the Office of Management National Institute on Drug Abuse;
and Budget (OMB) for each collection of Notice of Closed Meetings Center for Scientific Review; Notice of
information they conduct or sponsor. Pursuant to section 10(d) of the Closed Meetings
The term ‘‘collection of information’’ is Federal Advisory Committee Act, as Pursuant to section 10(d) of the
defined in 44 U.S.C. 3502(3) and 5 CFR amended (5 U.S.C. App), notice is Federal Advisory Committee Act, as
1320.3(c) and includes agency requests hereby given of the following meetings. amended (5 U.S.C. App.), notice is
or requirements that members of the The meetings will be closed to the hereby given of the following meetings.
public: submit reports, keep records, or public in accordance with the The meetings will be closed to the
provide information to a third party. To provisions set forth in sections public in accordance with the
comply with this requirement, CMS is 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., provisions set forth in sections
publishing this notice that summarizes as amended. The contract proposals and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
the following proposed collection(s) of the discussions could disclose as amended. The grant applications and
information for public comment: confidential trade secrets or commercial the discussions could disclose
Information Collection property such as patentable material, confidential trade secrets or commercial
and personal information concerning property such as patentable material,
1. Type of Information Collection individuals associated with the contract and personal information concerning
Request: Extension without change of a proposals, the disclosure of which individuals associated with the grant
previously approved collection; Title of would constitute a clearly unwarranted applications, the disclosure of which
Information Collection: Home Health invasion of personal privacy. would constitute a clearly unwarranted
Conditions of Participation (CoP) and Name of Committee: National Institute on invasion of personal privacy.
Supporting Regulations; Use: The Drug Abuse Special Emphasis Panel; Name of Committee: Center for Scientific
information collection requirements Technical Support for Constituency Outreach Review Special Emphasis Panel; PAR16–291
contained in this request are part of the & Research Dissemination (1157). Integrative Research on Polysubstance Abuse
requirements classified as the Date: April 4, 2017. and Addiction.
conditions of participation (CoPs) which Time: 10:00 a.m. to 12:00 p.m. Date: March 22, 2017.
are based on criteria prescribed in law Agenda: To review and evaluate contract Time: 1:00 p.m. to 3:00 p.m.
and are standards designed to ensure proposals. Agenda: To review and evaluate grant
Place: National Institutes of Health, applications.
that each facility has properly trained Neuroscience Center, 6001 Executive Place: National Institutes of Health, 6701
staff to provide the appropriate safe Boulevard, Rockville, MD 20852 (Telephone Rockledge Drive, Bethesda, MD 20892
physical environment for patients. Conference Call). (Telephone Conference Call).
These particular standards reflect Contact Person: Lyle Furr, Scientific Contact Person: Unja Hayes, Ph.D.,
comparable standards developed by Review Officer, Office of Extramural Affairs, Scientific Review Officer, National Institutes
industry organizations such as the Joint National Institute on Drug Abuse, NIH, of Health, Center for Scientific Review, 6701
Commission on Accreditation of DHHS, Room 4227, MSC 9550, 6001 Rockledge Drive, Bethesda, MD 20892, 301–
Healthcare Organizations, and the Executive Boulevard, Bethesda, MD 20892– 827–6830, unja.hayes@nih.gov.
Community Health Accreditation 9550, (301) 827–5702, lf33c.nih.gov. Name of Committee: Center for Scientific
Program. We will use this information Name of Committee: National Institute on Review Special Emphasis Panel; Small
along with state agency surveyors, the Drug Abuse Special Emphasis Panel; Purity Business: HIV/AIDS Innovative Research
Specifications, Storage & Distribution for Applications.
regional home health intermediaries and Medications Development (8934). Date: March 22, 2017.
home health agencies (HHAs) for the Date: April 20, 2017. Time: 3:00 p.m. to 5:00 p.m.
purpose of ensuring compliance with Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant
Medicare CoPs as well as ensuring the Agenda: To review and evaluate contract applications.
quality of care provided by HHA proposals. Place: National Institutes of Health, 6701
patients. Form Numbers: CMS–R–39 Place: National Institutes of Health, Rockledge Drive, Bethesda, MD 20892
(OMB control number: 0938–0365); Neuroscience Center, 6001 Executive (Virtual Meeting).
Frequency: Occasionally; Affected Boulevard, Rockville, MD 20852 (Telephone Contact Person: Mark P. Rubert, Ph.D.,
Public: Business or for-profits and Not- Conference Call). Scientific Review Officer, Center for
sradovich on DSK3GMQ082PROD with NOTICES

Contact Person: Lyle Furr, Scientific Scientific Review, National Institutes of
for-profit institutions, and State, Local Review Officer, Office of Extramural Affairs, Health, 6701 Rockledge Drive, Room 5218,
or Tribal governments; Number of National Institute on Drug Abuse, NIH, MSC 7852, Bethesda, MD 20892, 301–435–
Respondents: 13,577; Total Annual DHHS, Room 4227, MSC 9550, 6001 1775, rubertm@csr.nih.gov.
Responses: 20,202,576; Total Annual Executive Boulevard, Bethesda, MD 20892– Name of Committee: Center for Scientific
Hours: 6,422,694. (For policy questions 9550, (301) 827–5702, lf33c.nih.gov. Review Special Emphasis Panel; Surgical
regarding this collection contact (Catalogue of Federal Domestic Assistance Disparities Research.
Danielle Shearer at 410–786–6617.) Program No.: 93.279, Drug Abuse and Date: March 24, 2017.

VerDate Sep<11>2014 16:13 Mar 01, 2017 Jkt 241001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1

Document Created: 2017-03-02 00:09:20
Document Modified: 2017-03-02 00:09:20

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		April 4, 2017.
FR Citation		82 FR 12364

82 FR 12364 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 40 (March 2, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health